Publicaciones en colaboración con investigadores/as de Sahlgrenska University Hospital (1)

2017

  1. Inhibition of T-Cell activation by the CTLA4-Fc abatacept is sufficient to ameliorate proteinuric kidney disease

    American Journal of Physiology - Renal Physiology, Vol. 312, Núm. 4, pp. F748-F759